Tekla Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.37M | Hold |
65,490
| – | – | 0.09% | 108 |
|
|
2023
Q1 | $2.43M | Hold |
65,490
| – | – | 0.09% | 115 |
|
|
2022
Q4 | $2.97M | Sell |
65,490
-56,900
| -46% | -$2.58M | 0.11% | 101 |
|
|
2022
Q3 | $8.55M | Buy |
122,390
+38,606
| +46% | +$2.7M | 0.35% | 59 |
|
|
2022
Q2 | $5.62M | Hold |
83,784
| – | – | 0.22% | 83 |
|
|
2022
Q1 | $6.89M | Hold |
83,784
| – | – | 0.24% | 80 |
|
|
2021
Q4 | $12.3M | Hold |
83,784
| – | – | 0.4% | 59 |
|
|
2021
Q3 | $14.8M | Hold |
83,784
| – | – | 0.48% | 55 |
|
|
2021
Q2 | $13.5M | Hold |
83,784
| – | – | 0.44% | 58 |
|
|
2021
Q1 | $14.4M | Hold |
83,784
| – | – | 0.49% | 54 |
|
|
2020
Q4 | $18.4M | Buy |
83,784
+5,000
| +6% | +$1.1M | 0.65% | 42 |
|
|
2020
Q3 | $13.1M | Hold |
78,784
| – | – | 0.49% | 51 |
|
|
2020
Q2 | $9M | Hold |
78,784
| – | – | 0.34% | 61 |
|
|
2020
Q1 | $6.06M | Buy |
78,784
+7,911
| +11% | +$608K | 0.27% | 71 |
|
|
2019
Q4 | $9.13M | Sell |
70,873
-8,814
| -11% | -$1.14M | 0.35% | 68 |
|
|
2019
Q3 | $6.21M | Buy |
79,687
+66,097
| +486% | +$5.15M | 0.27% | 69 |
|
|
2019
Q2 | $1.4M | Hold |
13,590
| – | – | 0.06% | 150 |
|
|
2019
Q1 | $996K | Hold |
13,590
| – | – | 0.04% | 161 |
|
|
2018
Q4 | $576K | Hold |
13,590
| – | – | 0.02% | 184 |
|
|
2018
Q3 | $640K | Buy |
+13,590
| New | +$640K | 0.02% | 195 |
|